Mark Royston Quick
Corporate Officer/Principal at RECIPHARM AB (PUBL)
Network origin in Mark Royston Quick first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Holding Company | Biotechnology | 44 | |
The Open University
26
| College/University | Other Consumer Services | 26 |
Binx Health Ltd.
 Binx Health Ltd. Miscellaneous Commercial ServicesCommercial Services Part of binx health, inc., Binx Health Ltd. is a British company that engages in research and development on biotechnology. The company is based in Trowbridge, UK. The company was founded in 2005. The CEO is Jeffrey R. Luber.
9
| Subsidiary | Miscellaneous Commercial Services | 9 |
Flerie Invest AB
 Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden.
7
| Subsidiary | Investment Managers | 7 |
Nottingham Trent University
5
| College/University | Other Consumer Services | 5 |
Recipharm Fontaine SAS
 Recipharm Fontaine SAS Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm Fontaine SAS is a French pharmaceutical company that manufactures pharmaceutical products. The company is based in Fontaine-les-Dijon, France. The company was founded in 2008. Pascal Prudent has been the CEO of the company since 2017.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
ICI Chemicals & Polymers Ltd.
 ICI Chemicals & Polymers Ltd. Chemicals: Major DiversifiedProcess Industries ICI Chemicals & Polymers Ltd. manufactures chemicals and paints. The firm's products include petrochemicals, fertilizers, plastics, polymers, surfactants and industrial chemicals. It also manufactures CPs carried out by ICI Chemicals & Polymers Group. The company is headquartered in Middlesbrough, UK.
1
| Subsidiary | Chemicals: Major Diversified | 1 |
Recipharm Ltd.
 Recipharm Ltd. Pharmaceuticals: MajorHealth Technology Recipharm Ltd. manufactures pharmaceutical products. It offers branded and generic products. The company was founded on August 10, 2012 and is headquartered in Ashton-under-Lyne, the United Kingdom.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Recipharm HC Ltd.
 Recipharm HC Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2018, Recipharm HC Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. Part of Recipharm AB, the company is based in Cheshire, UK.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
UCB Pharma Ltd.
 UCB Pharma Ltd. Pharmaceuticals: MajorHealth Technology UCB Pharma Ltd. operates as a biopharmaceutical company. The firm focuses on developing medicines for severe diseases in Immunology and CNS. The company is headquartered in Slough, the United Kingdom.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Recipharm Holdings Ltd.
 Recipharm Holdings Ltd. MiscellaneousMiscellaneous Recipharm Holdings Ltd. operates from a multipurpose manufacturing facility, The company was founded on August 10, 2012 and is headquartered in Ashton-Under-Lyne, the United Kingdom.
1
| Subsidiary | Miscellaneous | 1 |
Aesica Holdco Ltd.
 Aesica Holdco Ltd. Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Aesica Holdco Ltd. operates as a holding British company. The company is based in Hemel Hempstead, UK.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Aesica Formulation Development Ltd.
 Aesica Formulation Development Ltd. Pharmaceuticals: MajorHealth Technology Aesica Formulation Development Ltd. develops pharmaceutical products. It offers sterile and nutraceutical product development and drug delivery services. The company was founded on December 22, 2005 and is headquartered in Northumberland, the United Kingdom.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mark Royston Quick via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| EXACT SCIENCES CORPORATION | Medical Specialties | Chief Executive Officer Chief Executive Officer | |
| CONSORT MEDICAL PLC | Pharmaceuticals: Major | Human Resources Officer Director/Board Member Director/Board Member | |
Helsinn Healthcare SA
 Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Consultant / Advisor | |
Provell Pharmaceuticals LLC
 Provell Pharmaceuticals LLC Medical DistributorsDistribution Services Provell Pharmaceuticals LLC is a healthcare company, which engages in marketing and distribution of pharmaceutical products. It offers products of Merck KGaA including Euthyrox. The company was founded by Jim Small and Kurt Kalm in 2005 and is headquartered in Honey Brook, PA. | Medical Distributors | Director/Board Member Director/Board Member | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| MEDA AB | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| MEDIVIR AB | Pharmaceuticals: Major | Chairman Chairman Director/Board Member | |
Apoteket AB
 Apoteket AB Drugstore ChainsRetail Trade Apoteket AB develops and manufactures drugs. The firm provides medication, health products, and services to individuals, health care business, and organizations. It sells and distributes drugs to nursing homes, home care, country councils, and municipalities. The company was founded in August, 1970 and is headquartered in Solna, Sweden. | Drugstore Chains | Director/Board Member Corporate Officer/Principal | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
EQT Partners AB
 EQT Partners AB Investment ManagersFinance EQT Partners AB (EQT Partners) is a private equity subsidiary of EQT AB founded in 1994 by Yngve Conni Jonsson. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Karolinska Institutet | College/University | Doctorate Degree Corporate Officer/Principal | |
| University of Cambridge | College/University | Graduate Degree Undergraduate Degree | |
| Stockholm School of Economics | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
| University of Uppsala | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
| University of Stockholm | College/University | Graduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
| Royal Institute of Technology | College/University | Graduate Degree Graduate Degree Graduate Degree | |
TFS Trial Form Support AB
 TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal | |
| University of Lisbon | College/University | Doctorate Degree Doctorate Degree | |
binx health, inc.
 binx health, inc. Information Technology ServicesTechnology Services Binx Health, Inc. develops and provides in vitro point-of-care (POC) testing on diseases such as sexually transmitted infections, neonatal sepsis and hospital acquired infections. Its technology products include in diagnostic and immunoassay platform, rapid POC, and nucleic acid detection technology. The company was founded by John Clarkson in 2005 and is headquartered in Trowbridge, the United Kingdom. | Information Technology Services | Chief Executive Officer Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
KAHR Medical Ltd.
 KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
SymCel AB
 SymCel AB Medical SpecialtiesHealth Technology SymCel AB develops and markets analytical instrumentations for cell biological research and development. Its products include calScreener, calPlate System, and calView date collection and analysis software. The company was founded by Dan Rolf Stefan Hallen and Bertil Ingemar Wadso in 2004 and is headquartered in Spanga, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
| XSPRAY PHARMA AB | Pharmaceuticals: Major | Director/Board Member Chairman | |
Apotek Produktion & Laboratorier AB
 Apotek Produktion & Laboratorier AB Pharmaceuticals: MajorHealth Technology Apotek Produktion & Laboratorier AB develops and manufactures pharmaceutical products. Its services include analytical services, clinical trials and contract manufacturing. The company is headquartered in Kungens Kurva, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Cobra Biologics Ltd.
 Cobra Biologics Ltd. Pharmaceuticals: MajorHealth Technology Cobra Biologics Ltd. engages in development of DNA-based technologies, services and products. It is a international contract development and manufacturing organization (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply. The company was founded in 1992 and is headquartered in Keele, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Recipharm Stockholm AB | Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member | ||
Recipharm Strängnäs AB
 Recipharm Strängnäs AB Miscellaneous Commercial ServicesCommercial Services Part of Recipharm AB, Recipharm Strängnäs AB is a contract development and manufacturing organization in the pharmaceutical industry. The company is based in Strängnäs, Sweden. Founded in 2004, Recipharm Strängnäs operates as a contract development and manufacturing organization in the pharmaceutical industry. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman Director/Board Member | |
Recipharm Karlskoga AB
 Recipharm Karlskoga AB Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm Karlskoga AB is a Swedish pharmaceutical company that manufactures pharmaceutical products. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member | |
Recip AB
 Recip AB Pharmaceuticals: MajorHealth Technology Part of Viatris, Inc., Recip AB is a company that manufactures pharmaceutical products. Recip AB is based in Arsta, Sweden. Recip was acquired by Meda AB, part of Viatris, Inc. from August 24, 2016 on December 31, 2007 for $475.65 million. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| Swedish Pharmaceutical Society | Corporate Officer/Principal Chairman Chairman | ||
Cobra Biologics Holding AB
 Cobra Biologics Holding AB Pharmaceuticals: MajorHealth Technology Cobra Biologics Holding AB manufactures biologics and pharmaceuticals for pre-clinical, clinical, and commercial products. Its services include gene therapies and vaccines, products for testing, process development and scale up of vaccine products, production of sterile drug products, and process development and production, automation, and traceability of programs. The company was founded in 2011 and is headquartered in S?dert?lje, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Cormorant Pharmaceuticals AB
 Cormorant Pharmaceuticals AB BiotechnologyHealth Technology Cormorant Pharmaceuticals AB provides biopharmaceutical products.The company was founded by Maarten de Chateau and Urban Paulsson in 2010 and is headquartered in Solna, Sweden. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| Recipharm Höganäs AB | Biotechnology | Director/Board Member Director/Board Member Chairman Director/Board Member | |
| Recipharm Pharmaceutical Development AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Linköping Institute of Technology | College/University | Graduate Degree Graduate Degree | |
Empros Pharma AB
 Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| Recipharm (Venture Capital) | Investment Managers | Director/Board Member Chief Executive Officer | |
Atrogi AB
 Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member Chairman | |
RPH Pharmaceuticals AB
 RPH Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, RPH Pharmaceuticals AB is a Swedish company that manufactures pharmaceutical products. The company is based in Jordbro, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Prokarium Ltd.
 Prokarium Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Ltd. operates as a biopharmaceutical company that focuses on developing vaccination solutions based on synthetic biology. Its oral vaccine delivery platform Vaxonella stimulates broad protective immune responses applicable to a wide range of diseases. The company is headquartered in Keele, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member | |
Prokarium Holdings Ltd.
 Prokarium Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Holdings Ltd. provides management services. The private company is based in London, UK. The British company was founded in 2014. Kristen Albright has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member | |
Buzzard Pharmaceuticals AB
 Buzzard Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Buzzard Pharmaceuticals AB develops oncology drugs. The company is based in Stockholm, Sweden. The Swedish company was founded by Urban Paulsson. The CEO is Maarten de Château. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Ariceum Therapeutics GmbH
 Ariceum Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services Ariceum Therapeutics GmbH is a German clinical stage radiopharmaceutical company that focuses on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers. Ariceum Therapeutics is based in Berlin, DE, and has subsidiaries in various locations worldwide. The company's lead targeted systemic radiopharmaceutical product, -satoreotide tetraxetan ("satoreotide"), is an antagonist of the somatostatin type 2 (sstr2) receptor, which is overexpressed in neuroendocrine tumors (NETs) and some aggressive cancers such as small cell lung cancer (SCLC) and Merkel cell carcinoma. Ariceum is also developing a radiolabeled PARP-inhibitor (ATT-001), which is slated to enter the clinic in early 2024. The company was founded in 2021, and Manfred Rüdiger has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member |
Statistics
International
| Sweden | 39 |
| United Kingdom | 6 |
| United States | 4 |
| Switzerland | 2 |
| Portugal | 2 |
Sectoral
| Health Technology | 26 |
| Commercial Services | 10 |
| Consumer Services | 9 |
| Finance | 3 |
| Distribution Services | 2 |
Operational
| Director/Board Member | 428 |
| Corporate Officer/Principal | 166 |
| Chairman | 104 |
| Chief Executive Officer | 86 |
| Independent Dir/Board Member | 64 |
Most connected contacts
- Stock Market
- Insiders
- Mark Royston Quick
- Company connections
